Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1954 2
1964 1
1965 1
1969 1
1972 1
1974 1
1975 3
1976 2
1977 5
1978 7
1979 4
1980 3
1981 7
1982 6
1983 4
1984 5
1985 9
1986 3
1987 3
1988 2
1989 2
1990 1
1991 2
1992 7
1993 3
1994 4
1995 1
1996 4
1997 5
1998 4
1999 1
2000 2
2001 3
2003 2
2004 5
2009 1
2010 5
2011 3
2012 2
2013 1
2014 8
2015 9
2016 3
2017 4
2018 5
2019 3
2020 7
2021 5
2022 7
2023 7
2024 2
2025 5
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
ARMC2 loss impairs cilia structure and leads to primary ciliary dyskinesia symptoms in mouse organs.
Giordani E, Houdeline S, Court M, Gory-Fauré S, Deloulme JC, Bouin AP, Senger F, Coutton C, Del Llano E, Barbotin AL, Boursier A, Chevalier G, Bertrand A, Bosc C, Escoffier J, Ray PF, Martinez G, Arnoult C, Loeuillet C. Giordani E, et al. Among authors: chevalier g. Front Cell Dev Biol. 2026 May 26;14:1695239. doi: 10.3389/fcell.2026.1695239. eCollection 2026. Front Cell Dev Biol. 2026. PMID: 42272638 Free PMC article.
EB1010, a putative Christensenellaceae-derived microbial peptide, exhibits anti-inflammatory activity and therapeutic potential in ulcerative colitis.
Orsini Delgado ML, Baudesson de Chanville C, Pfister H, Bardouillet L, Farin W, Rinaudo P, Quessel J, Strozzi F, Pereira H, Maresca M, Nicoletti C, Di Pasquale E, Mailhac C, Thomas V, Blum S, Chevalier G, Toussaint H, Luangsay S, Bonny C, Chene L, Cultrone A. Orsini Delgado ML, et al. Among authors: chevalier g. Gut Microbes. 2026 Dec 31;18(1):2662547. doi: 10.1080/19490976.2026.2662547. Epub 2026 Apr 25. Gut Microbes. 2026. PMID: 42033239 Free PMC article.
Sperm motility in mice with oligo-astheno-teratozoospermia restored by in vivo injection and electroporation of naked mRNA.
Vilpreux C, Fourquin P, Martinez G, Court M, Appaix F, Duteyrat JL, Henry M, Vollaire J, Ayad C, Yavuz A, Chevalier G, De Macedo L, Rebelo SA, Del Llano E, Tebbakh C, Kherraf ZE, Lambert E, Ahmed Conté S, Wehbe Z, Giordani E, Josserand V, Brocard J, Coutton C, Verrier B, Ray PF, Loeuillet C, Arnoult C, Escoffier J. Vilpreux C, et al. Among authors: chevalier g. Elife. 2026 Mar 3;13:RP94514. doi: 10.7554/eLife.94514. Elife. 2026. PMID: 41773826 Free PMC article.
Hemodynamics and transplacental oxygen exchange during intact cord resuscitation in control and congenital diaphragmatic hernia lambs.
Le Duc K, Manœuvrier F, Rougraff C, Teillet B, Maboudou P, Wojtanowski A, Besengez C, Chevalier G, Ghesquiere L, Garabedian C, Mur S, Boukhris R, Storme L, Sharma D. Le Duc K, et al. Among authors: chevalier g. Am J Physiol Heart Circ Physiol. 2026 Apr 1;330(4):H946-H954. doi: 10.1152/ajpheart.00388.2025. Epub 2026 Jan 28. Am J Physiol Heart Circ Physiol. 2026. PMID: 41605468 Free article.
[Evaluation of the rate of attempted vaginal delivery for French breech presentation protocols].
Masquelier S, Garabedian C, Lallemant M, Gilbert M, Bailleux T, Ghesquiere L, Vanspranghels R, Hamoud YO, Rakza T, Subtil D, Chevalier G. Masquelier S, et al. Among authors: chevalier g. Gynecol Obstet Fertil Senol. 2025 Oct;53(10):506-511. doi: 10.1016/j.gofs.2025.06.002. Epub 2025 Jun 6. Gynecol Obstet Fertil Senol. 2025. PMID: 40484200 Free article. French.
Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.
Talpin A, Maia A, Carpier JM, Kulakowski G, Aubergeon L, Kervevan J, Gaal C, Strozzi F, Billerey C, Amable L, Mersceman T, Garnier A, Oliveira C, Calderon C, Bachrouche D, Ventujol C, Bernard L, Manteau A, Martinez J, Bonnet M, Noguerol J, Laviolette K, Boullerot L, Malfroy M, Chevalier G, Adotevi O, Joffre O, Idbaih A, Vieito M, Ghiringhelli F, Stradella A, Tabatabai G, Burger MC, Mildenberger I, Herrlinger U, Reardon DA, Wick W, Gouttefangeas C, Bonny C, Chene L, Gamelas Magalhaes J. Talpin A, et al. Among authors: chevalier g. J Immunother Cancer. 2025 Feb 20;13(2):e010192. doi: 10.1136/jitc-2024-010192. J Immunother Cancer. 2025. PMID: 39979071 Free PMC article.
An Open-Label, Non-randomized, Drug-Repurposing Study to Explore the Clinical Effects of Angiotensin II Type 1 (AT1) Receptor Antagonists on Anxiety and Depression in Parkinson's Disease.
Bordet S, Grasso L, Udovin L, Chevalier G, Otero-Losada M, Capani F, Perez-Lloret S. Bordet S, et al. Among authors: chevalier g. Mov Disord Clin Pract. 2025 May;12(5):653-658. doi: 10.1002/mdc3.14326. Epub 2025 Jan 18. Mov Disord Clin Pract. 2025. PMID: 39825674 Free PMC article.
191 results